EP2 receptor signaling pathways regulate classical activation of microglia

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Prostaglandin E2 (PGE2) and its EP2 receptors are implicated in neuroinflammation associated with neurodegenerative diseases.
• The precise signaling pathways downstream of EP2 receptor activation in microglia remain incompletely understood.

Purpose of the Study:

• To investigate the role of EP2 receptor activation in regulating inflammatory responses in rat microglia.
• To elucidate the specific intracellular signaling pathways, including protein kinase A (PKA) and cAMP-regulated guanine nucleotide exchange factors (Epacs), involved in EP2 receptor-mediated microglial activation.

Main Methods:

• Primary rat microglia were cultured and subjected to classical activation using lipopolysaccharide and interferon-γ.
• Real-time PCR and protein measurements were used to assess the expression of various inflammatory mediators.
• Specific EP2 receptor agonists and antagonists, along with PKA and Epac pathway modulators, were employed to dissect signaling mechanisms.

Main Results:

• EP2 receptor activation by PGE2 or its agonist butaprost modulated the expression of specific inflammatory mediators, exacerbating some (e.g., IL-6, IL-1β) while blunting others (e.g., TNF-α, IL-10).
• These effects were predominantly mediated through Epac pathways, as evidenced by the mimicry of butaprost's actions by an Epac activator and the minimal impact of a PKA inhibitor.
• In resting microglia, EP2 activation increased cAMP but did not alter protein expression of inflammatory mediators.

Conclusions:

• EP2 receptor activation exerts a complex regulatory role in the classical activation of microglia.
• The Epac signaling pathway is a major mediator of EP2 receptor-induced changes in microglial inflammatory gene expression.
• These findings contribute to understanding the molecular mechanisms underlying neuroinflammation in neurodegenerative conditions.